Anteilseigner
RA Capital Management LP (18,68 %) RTW Investments LP (9,41 %) Fidelity Management & Research Co. LLC (8,63 %) TD Securities (USA) LLC (5,98 %) Suvretta Capital Management LLC (4,58 %) The Vanguard Group, Inc. (4,05 %) Third Rock Ventures LLC (3,77 %) BlackRock Fund Advisors (2,40 %) Citadel Advisors LLC (2,12 %) Dimensional Fund Advisors LP (1,90 %) Jefferies Investment Advisers LLC (1,85 %) MPM BioImpact, Inc (1,83 %) Adage Capital Management LP (1,78 %) Morgan Stanley & Co. LLC (1,67 %) Millennium Management LLC (1,44 %) DWS Investments (UK) Ltd. (1,32 %) Goldman Sachs & Co. LLC (Private Banking) (1,28 %) Propel Bio Management LLC (1,21 %) Rock Springs Capital Management LP (1,17 %) Qube Research & Technologies Ltd. (1,16 %)
Kontakt
Fulcrum Therapeutics Inc.